Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin Read more about Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers Read more about Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Regulation of Endogenous Glucose Production by Central KATP Channels Read more about Regulation of Endogenous Glucose Production by Central KATP Channels
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Read more about Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF) Read more about Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
Transformative Research in Diabetic Nephropathy Read more about Transformative Research in Diabetic Nephropathy
Medical Cannabis During Chemoradiation for Head and Neck Cancer Read more about Medical Cannabis During Chemoradiation for Head and Neck Cancer
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Read more about Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer Read more about Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma Read more about Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma